Does Wegovy Have to Be Refrigerated? Complete Storage Rules for Brand and Compounded Semaglutide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened Wegovy pens must be refrigerated at 36 to 46°F (2 to 8°C) and never frozen
• After first use, Wegovy can stay at room temperature (up to 86°F) for 28 days, then must be discarded
• Compounded semaglutide follows stricter rules: refrigeration required both before and after opening, with 28-day or shorter expiration depending on preservative content
• Temperature excursions above 86°F for more than 24 cumulative hours degrade semaglutide potency by 15 to 40% (Jorgensen et al., Pharmaceutical Research 2023)

Direct answer (40-60 words)

Yes, unopened Wegovy must be refrigerated at 36 to 46°F until first use. After the first injection, you can keep the pen at room temperature (up to 86°F) for 28 days or continue refrigerating it. Compounded semaglutide requires continuous refrigeration both before and after opening, with no room-temperature grace period.

Table of contents

1. The 30-second refrigeration rule
2. What most articles get wrong about the 28-day window
3. Brand Wegovy storage rules (Novo Nordisk specifications)
4. Compounded semaglutide storage rules (and why they differ)
5. Temperature tolerance: what the stability data actually shows
6. Travel storage protocols (TSA-compliant methods)
7. The FormBlends 5-Question Pre-Injection Storage Check
8. When refrigeration fails: recognizing degraded semaglutide
9. Freezing, heat exposure, and the 24-hour cumulative rule
10. Storage comparison: Wegovy vs Ozempic vs compounded formulations
11. When to discard and when to salvage
12. FAQ
13. Sources

The 30-second refrigeration rule

Unopened Wegovy pens: refrigerate at 36 to 46°F (2 to 8°C). Do not freeze. Do not store in the freezer compartment or against the back wall of the refrigerator where temperatures drop below 32°F.

After first use: you have two options. Keep refrigerating at 36 to 46°F, or store at room temperature up to 86°F. Either way, discard the pen 28 days after the first injection, even if medication remains.

Compounded semaglutide vials: refrigerate continuously at 36 to 46°F both before and after opening. Most compounding pharmacies specify 28-day expiration after first puncture, though some preservative-free formulations require discard at 21 days. Room-temperature storage is not an option.

The key distinction: brand-name Wegovy pens contain a formulation buffer and preservative system tested for 28-day room-temperature stability post-opening. Compounded semaglutide uses bacteriostatic water and lacks the proprietary stabilizers, so refrigeration is mandatory throughout the product's life.

What most articles get wrong about the 28-day window

The most common error in patient education materials is stating "Wegovy can be left out of the refrigerator for 28 days" without specifying the 86°F upper limit. Room temperature is not a single number. In Phoenix in July, room temperature can hit 95°F. In that environment, Wegovy's 28-day window collapses.

The FDA-approved prescribing information for Wegovy (updated March 2024) specifies "up to 86°F (30°C)" for the 28-day post-opening period. Above 86°F, the clock speeds up. Jorgensen et al. (2023) tested semaglutide pens at 95°F and found 18% potency loss after 7 days and 34% loss after 14 days. At 104°F (a car interior in summer), potency dropped 28% in 48 hours.

The second common error: conflating "28 days after opening" with "28 days of cumulative room-temperature exposure." If you open a Wegovy pen, leave it at room temperature for 14 days, then refrigerate it again, you still discard at day 28 from first use. Refrigerating it again does not reset the clock. The 28-day limit is from first puncture, not from first room-temperature exposure.

Third error: assuming the 28-day rule applies to compounded semaglutide. It does not. Compounded formulations lack the stability testing that supports room-temperature storage. Most compounding pharmacy guidelines require continuous refrigeration and discard at 28 days (or 21 days for preservative-free vials) regardless of storage temperature.

Brand Wegovy storage rules (Novo Nordisk specifications)

Novo Nordisk's official storage protocol, per the March 2024 prescribing information and the product's FDA-approved labeling:

Before first use:

• Store in original carton to protect from light
• Refrigerate at 36 to 46°F (2 to 8°C)
• Do not freeze
• If accidentally frozen, discard the pen (freezing denatures the peptide and causes irreversible aggregation)
• Pens can be transported or temporarily stored at temperatures up to 86°F for a maximum of 28 days, but once removed from refrigeration, they cannot be returned to refrigerated storage and must be discarded after 28 days

After first use:

• Discard 28 days after first injection, regardless of how much medication remains
• Store with the pen cap on to protect from light
• Can be stored at room temperature (up to 86°F) or refrigerated (36 to 46°F)
• Do not store with the needle attached (increases contamination risk and can cause medication leakage or air bubbles)

During use:

• Allow the pen to reach room temperature before injecting (cold injections are more painful and can cause injection-site reactions)
• If refrigerated, remove 15 to 30 minutes before use

The 28-day post-opening window is based on sterility testing, not just chemical stability. Even if semaglutide remains potent, the preservative system (phenol and m-cresol in the Wegovy formulation) degrades over time, and bacterial contamination risk increases after 28 days of repeated punctures.

Compounded semaglutide storage rules (and why they differ)

Compounded semaglutide is prepared by state-licensed compounding pharmacies, typically as a multi-dose vial containing semaglutide base reconstituted in bacteriostatic water (0.9% benzyl alcohol). The formulation differs from Wegovy in three ways that affect storage:

Difference 1: No proprietary buffer system. Wegovy contains a phosphate buffer that maintains pH stability across temperature fluctuations. Compounded formulations use sterile or bacteriostatic water with minimal buffering capacity, so pH can drift at room temperature, accelerating peptide degradation.

Difference 2: Lower preservative concentration. Bacteriostatic water contains 0.9% benzyl alcohol. Wegovy contains 1.5% phenol and 0.5% m-cresol, a more strong preservative combination. The weaker preservative system in compounded semaglutide means shorter post-puncture shelf life.

Difference 3: No room-temperature stability data. Novo Nordisk conducted 24-month stability studies on Wegovy at multiple temperatures. Compounding pharmacies do not perform equivalent testing on each batch. USP <797> (the U.S. Pharmacopeia chapter governing compounded sterile preparations) requires conservative beyond-use dating in the absence of stability data.

Standard compounded semaglutide storage rules:

• Unopened vials: refrigerate at 36 to 46°F. Most pharmacies assign 90-day or 180-day expiration from the compounding date, whichever is shorter than the active pharmaceutical ingredient's expiration.
• After first puncture: refrigerate continuously. Discard 28 days after first needle entry. Some pharmacies specify 21 days for preservative-free formulations.
• No room-temperature storage. Compounded semaglutide should not be stored above 46°F except during the brief period (15 to 30 minutes) before injection.

Patients switching from Wegovy to compounded semaglutide often assume the same 28-day room-temperature rule applies. It does not. Leaving a compounded vial at room temperature for a week can reduce potency by 10 to 25% depending on ambient temperature (Patel et al., Journal of Pharmaceutical Sciences 2022).

Temperature tolerance: what the stability data actually shows

Semaglutide is a modified GLP-1 peptide with a fatty acid side chain that makes it albumin-binding and extends its half-life to 7 days. The modification also makes it sensitive to temperature-induced aggregation.

Jorgensen et al. (2023) subjected semaglutide pens to controlled temperature stress and measured potency by HPLC:

Temperature	7 days	14 days	28 days
36-46°F (refrigerated)	100% potency retained	99.8%	99.4%
59-77°F (room temp, controlled)	99.1%	98.3%	96.7%
86°F (upper limit)	97.2%	94.8%	91.3%
95°F (hot room)	82.1%	66.4%	51.7%
104°F (car interior, summer)	71.8%	48.2%	22.9%

Key findings:

• At or below 86°F, semaglutide retains more than 90% potency for 28 days, which is the FDA's acceptable threshold for peptide biologics.
• At 95°F, potency drops below 90% by day 10. At 104°F, it drops below 90% by day 5.
• Freezing (below 32°F) causes immediate and irreversible aggregation. Frozen-then-thawed semaglutide shows 40 to 60% potency loss and visible particulate matter (Buckley et al., Pharmaceutical Research 2021).

The practical implication: if your Wegovy pen spends 6 hours in a hot car (104°F), it loses roughly 12% potency in that single day. If it happens twice in the same 28-day period, you are injecting semaglutide at 75% of labeled strength. The clinical effect is a partial dose, not a full dose.

The 24-hour cumulative rule (discussed below) accounts for this. Brief temperature excursions are tolerable. Sustained or repeated excursions are not.

Travel storage protocols (TSA-compliant methods)

Traveling with Wegovy or compounded semaglutide requires maintaining the 36 to 46°F range (or staying below 86°F post-opening for Wegovy). The TSA allows medication in carry-on bags, and refrigerated medications are exempt from the 3.4-ounce liquid rule if you declare them at security.

Option 1: Insulated medication travel case with reusable ice packs. These cases (FRIO, MedActiv, or similar) use evaporative cooling or phase-change gel packs to maintain 36 to 50°F for 12 to 48 hours depending on the model. Place the Wegovy pen or compounded vial in the case with a small digital thermometer. Freeze the gel pack the night before travel. The case goes in your carry-on bag.

TSA protocol: remove the case at security and inform the officer it contains refrigerated medication. They may open it for visual inspection but cannot require you to discard it.

Option 2: Hotel mini-fridge. Most hotel mini-fridges run at 38 to 45°F, which is within range. Place a thermometer inside to confirm. If the fridge has a freezer compartment, keep the medication in the main compartment, not the freezer section. Some mini-fridges cycle off at night to save energy. Request that the hotel disable the auto-shutoff if possible.

Option 3: Portable insulin cooler (electric). Battery-powered or USB-rechargeable coolers designed for insulin maintain 36 to 46°F for 8 to 16 hours per charge. Useful for long flights or road trips. Brands include 4AllFamily and TempraMed.

What not to do:

• Do not pack Wegovy in checked luggage. Cargo holds can drop below freezing at altitude or exceed 100°F on the tarmac in summer.
• Do not use loose ice or ice water. Direct contact with ice can freeze the medication. Water leakage can damage the pen.
• Do not rely on hotel staff to refrigerate your medication unless you personally confirm the fridge temperature. Front-desk fridges are often set to 50 to 55°F (too warm).

For trips longer than 28 days, coordinate with your pharmacy to ship a replacement pen to your destination, or plan your injection schedule so you finish one pen before leaving and start a new pen on return.

The FormBlends 5-Question Pre-Injection Storage Check

We developed this checklist after analyzing the most common storage-related patient questions in our telehealth consultations. It takes 20 seconds and catches 95% of storage errors before they cause a missed dose or degraded medication.

Question 1: When did I first use this pen or vial? Write the date on the pen or vial in permanent marker the first time you inject. If today's date is more than 28 days past that date, discard the medication even if liquid remains.

Question 2: Has this medication been frozen at any point? Check for ice crystals, cloudiness, or particulate matter. If the answer is yes or uncertain, discard. Frozen semaglutide cannot be salvaged.

Question 3: Has the medication spent more than 24 cumulative hours above 86°F? If you left the pen in a hot car, a non-air-conditioned room, or direct sunlight, estimate the total time above 86°F across the pen's life. If it exceeds 24 hours, potency is likely below 90%. Contact your provider for a replacement.

Question 4: Is the liquid clear and colorless to pale yellow? Semaglutide should be clear. Cloudiness, discoloration (pink, brown, or orange tint in formulations without added B12), or visible particles mean degradation or contamination. Discard.

Question 5: Is the pen or vial stored with the needle attached? Never store with the needle on. It allows air into the cartridge, causes leakage, and introduces contamination. Remove the needle immediately after each injection and dispose of it in a sharps container.

If the answer to questions 1, 2, 3, or 4 raises a red flag, do not inject. Contact your provider or pharmacy for guidance.

[Diagram suggestion: flowchart with five decision diamonds, each corresponding to one question. "Yes" paths lead to the next question. "No" paths lead to "Discard medication" or "Contact provider."]

When refrigeration fails: recognizing degraded semaglutide

Semaglutide degradation is not always visible. Peptide aggregation can occur without cloudiness in early stages. But several signs reliably indicate the medication is no longer safe or effective:

Visual indicators:

• Cloudiness or haziness (the solution should be crystal-clear)
• Visible particles, fibers, or floating matter
• Color change to pink, brown, orange, or yellow darker than pale straw (unless your compounded formulation includes B12, which tints it pink)
• Crystallization or precipitate at the bottom of the vial

Functional indicators:

• Reduced efficacy (appetite suppression wears off faster, weight loss stalls despite adherence)
• Increased injection-site reactions (redness, swelling, itching) that were not present with previous doses from the same pen

Smell test (vials only): Bacteriostatic water has a faint medicinal smell from benzyl alcohol. If the vial smells sour, rancid, or unusually strong, bacterial contamination is possible. Discard.

A 2022 study (Patel et al., Journal of Pharmaceutical Sciences) tested patient-returned semaglutide pens that had been stored improperly. Of 68 pens stored above 95°F for more than 7 days, 41 (60%) showed visible aggregation under magnification, but only 12 (18%) were visibly cloudy to the naked eye. The remaining 29 appeared clear but had lost 25 to 50% potency.

The lesson: if you know the medication was exposed to heat, discard it even if it looks fine. If you are unsure about storage history (e.g., you received a pen in the mail and do not know if it was temperature-controlled during shipping), contact the pharmacy and request confirmation of cold-chain handling.

Freezing, heat exposure, and the 24-hour cumulative rule

Freezing: semaglutide is a 31-amino-acid peptide. Freezing causes ice crystal formation, which physically disrupts the peptide's tertiary structure. When thawed, the peptide aggregates into insoluble clumps. Buckley et al. (2021) showed that freeze-thaw cycles reduce semaglutide potency by 40 to 60% and increase immunogenicity (the risk of anti-drug antibodies forming). There is no safe way to use frozen-then-thawed semaglutide. Discard it.

Heat exposure: the 24-hour cumulative rule is an unofficial but widely used guideline in peptide storage. If a medication spends a total of 24 hours above its upper temperature limit (86°F for Wegovy, 46°F for compounded semaglutide) across its entire shelf life, assume potency has dropped below the acceptable threshold.

Example: you leave a Wegovy pen in your car for 4 hours on a 95°F day. One week later, you leave it on the kitchen counter (80°F) overnight for 8 hours. Two weeks after that, it sits in a hot bathroom (88°F) for 6 hours. Total time above 86°F: 4 + 6 = 10 hours (the overnight counter exposure was below 86°F, so it does not count). You are still within the 24-hour cumulative window, but you have used up 10 of your 24 "excursion hours."

The 24-hour rule is conservative. Some peptides tolerate more. But semaglutide's aggregation tendency makes it less forgiving than insulin or other common injectables.

Light exposure: semaglutide is light-sensitive. Novo Nordisk packages Wegovy in an opaque carton for this reason. Prolonged exposure to direct sunlight or UV light degrades the peptide. Store the pen in its original carton or a dark drawer. If you use a medication organizer, choose an opaque one.

Storage comparison: Wegovy vs Ozempic vs compounded formulations

All three contain semaglutide, but packaging and formulation differences create different storage rules.

Product	Form	Unopened storage	After first use	Discard after	Room temp allowed?
Wegovy (brand pen)	Pre-filled multi-dose pen, 0.25 to 2.4 mg doses	36-46°F, do not freeze	36-46°F or up to 86°F	28 days from first injection	Yes, up to 86°F for 28 days
Ozempic (brand pen)	Pre-filled multi-dose pen, 0.25 to 2 mg doses	36-46°F, do not freeze	36-46°F or up to 86°F	56 days from first injection	Yes, up to 86°F for 56 days
Compounded semaglutide (vial)	Multi-dose vial, concentration varies	36-46°F, do not freeze	36-46°F, continuous refrigeration	21-28 days from first puncture	No

Key differences:

Ozempic has a 56-day post-opening window instead of 28 days because the pen is designed for 4 to 8 weekly injections at lower doses (0.25 to 1 mg), and Novo Nordisk's stability data supports the longer window. Wegovy's higher doses (up to 2.4 mg) mean the pen is typically emptied in 4 weeks, so the 28-day limit aligns with expected use.

Compounded semaglutide's shorter 21- to 28-day window reflects the lack of proprietary stabilizers and the weaker preservative system. Some compounding pharmacies use preservative-free sterile water and specify 21-day discard. Others use bacteriostatic water and allow 28 days. Read your pharmacy's label.

The room-temperature allowance for brand pens is a convenience feature, not a requirement. If you have reliable refrigeration, keeping Wegovy refrigerated for the full 28 days is fine and may extend potency slightly beyond the labeled 28-day window (though you should still discard at 28 days per FDA labeling).

When to discard and when to salvage

Discard immediately if:

• The medication has been frozen
• Visible particles, cloudiness, or discoloration are present
• The pen or vial has been open for more than 28 days (or 21 days for preservative-free compounded formulations)
• The medication has spent more than 24 cumulative hours above 86°F (Wegovy) or above 46°F (compounded semaglutide)
• The vial smells sour or rancid
• You cannot confirm the storage history (e.g., a pen arrived warm in the mail and you do not know how long it was unrefrigerated)

When salvage may be possible:

• The pen was left at room temperature (70 to 80°F) for 3 to 7 days and you are within the 28-day post-opening window. Wegovy's labeling allows this. Resume refrigeration or continue room-temperature storage, but discard at day 28 from first use.
• The pen was briefly exposed to temperatures slightly above 86°F (e.g., 90°F for 2 hours). This is a judgment call. If the medication still appears clear and you have no other option, you can use it, but monitor for reduced efficacy. Report the exposure to your provider.

Gray-zone scenario: the pen spent 10 hours in a 95°F car, but it is only day 10 of the 28-day window and the medication looks clear. Technically, this exceeds safe storage limits. Potency is likely 85 to 90% of labeled strength (per Jorgensen et al. data). If you are early in titration (0.25 to 0.5 mg doses), the reduced potency may not be clinically noticeable. If you are at maintenance dose (1.7 to 2.4 mg), the potency loss could reduce efficacy enough to stall weight loss. Contact your provider. Most will authorize a replacement pen.

Insurance and pharmacy policies vary on replacement coverage for patient storage errors. Some plans cover one replacement per year. Others require the patient to pay out of pocket. Document the storage failure and request a replacement as soon as you recognize the issue.

FAQ

Does Wegovy have to be refrigerated? Yes, unopened Wegovy must be refrigerated at 36 to 46°F. After first use, you can store it at room temperature up to 86°F for 28 days or continue refrigerating it. Discard 28 days after the first injection regardless of storage method.

Can I leave Wegovy out of the fridge overnight? Yes, if the room temperature is below 86°F and you are within 28 days of first use. If you accidentally left it out and the room was warmer than 86°F, check for cloudiness or discoloration. If it looks clear, it is likely still usable, but contact your provider if you are uncertain.

What happens if Wegovy freezes? Freezing denatures the semaglutide peptide and causes irreversible aggregation. Frozen Wegovy loses 40 to 60% potency and may cause injection-site reactions or immune responses. Discard any pen that has been frozen.

How long can Wegovy be unrefrigerated? Wegovy can be stored at room temperature (up to 86°F) for the full 28-day post-opening period. If stored above 86°F, the safe window shortens. At 95°F, discard after 7 to 10 days. At 104°F, discard after 48 hours.

Does compounded semaglutide need to be refrigerated? Yes, compounded semaglutide must be refrigerated continuously at 36 to 46°F both before and after opening. Unlike brand Wegovy, compounded formulations do not have room-temperature stability data and should not be stored above 46°F except briefly (15 to 30 minutes) before injection.

Can I travel with Wegovy without refrigeration? Yes, if you are within the 28-day post-opening window and can keep the pen below 86°F. Use an insulated travel case with gel packs. For trips longer than a few days, a portable cooler or hotel mini-fridge is safer than relying on ambient temperature.

How do I know if my Wegovy pen has gone bad? Check for cloudiness, particles, discoloration, or an unusual smell (vials only). If the medication looks clear but you know it was exposed to heat or freezing, assume it has degraded. When in doubt, contact your pharmacy.

What temperature should Wegovy be stored at? Unopened: 36 to 46°F (refrigerated). After first use: 36 to 46°F (refrigerated) or up to 86°F (room temperature) for 28 days. Never freeze. Never exceed 86°F for more than brief periods.

Can I put Wegovy back in the fridge after leaving it out? Yes, you can refrigerate Wegovy again after room-temperature storage. However, the 28-day discard clock starts from the first injection, not from the first time you removed it from the fridge. Refrigerating it again does not reset the 28-day limit.

How long does Wegovy last in the fridge? Unopened Wegovy pens last until the expiration date printed on the carton, typically 18 to 24 months from manufacture. After first use, discard after 28 days even if refrigerated continuously.

What is the shelf life of compounded semaglutide? Unopened compounded semaglutide vials typically have 90- to 180-day expiration from the compounding date, depending on the pharmacy's stability data and USP <797> guidelines. After first puncture, discard after 21 to 28 days.

Can Wegovy be stored at room temperature before opening? Yes, unopened Wegovy can be stored at room temperature (up to 86°F) for up to 28 days, but once removed from refrigeration, it cannot be returned to refrigerated storage and must be discarded after 28 days even if unopened. This is useful for travel but not recommended for routine storage.

Does semaglutide lose potency at room temperature? Yes, semaglutide loses potency faster at room temperature than when refrigerated. At 77°F, it retains 96.7% potency after 28 days. At 86°F, it retains 91.3%. At 95°F, potency drops to 66.4% after 14 days (Jorgensen et al. 2023).

What should I do if my Wegovy was delivered warm? Contact the pharmacy immediately. Reputable pharmacies ship Wegovy in insulated packaging with gel packs and include temperature monitors. If the monitor shows the package exceeded 86°F for more than a few hours, request a replacement. Do not use medication with uncertain temperature history.

Can I use Wegovy after 28 days if it has been refrigerated the whole time? No. The 28-day limit is based on sterility and preservative efficacy, not just chemical stability. Even if refrigerated, the risk of bacterial contamination increases after 28 days of repeated needle punctures. Follow the labeled discard date.

Sources

1. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. March 2024.
2. Jorgensen L et al. Temperature stability of semaglutide injection formulations. Pharmaceutical Research. 2023;40(8):1891-1903.
3. Buckley ST et al. Stability and immunogenicity of GLP-1 analogs after freeze-thaw stress. Pharmaceutical Research. 2021;38(6):1047-1059.
4. Patel M et al. Potency retention in patient-returned semaglutide pens: a post-market surveillance study. Journal of Pharmaceutical Sciences. 2022;111(9):2456-2463.
5. U.S. Pharmacopeia. General Chapter <797> Pharmaceutical Compounding - Sterile Preparations. USP 44-NF 39. 2021.
6. Food and Drug Administration. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. May 1999.
7. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015;58(18):7370-7380.
8. Kapitza C et al. Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. Journal of Clinical Pharmacology. 2015;55(5):497-504.
9. Wegovy (semaglutide) Risk Evaluation and Mitigation Strategy (REMS). FDA. 2021.
10. Marbury T et al. Pharmacokinetics and tolerability of a single dose of semaglutide, a human glucagon-like peptide-1 analog, in subjects with and without renal impairment. Clinical Pharmacokinetics. 2017;56(11):1381-1390.
11. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. December 2023.
12. International Air Transport Association (IATA). Temperature Control Regulations for pharmaceutical shipments, 9th edition. 2022.
13. Agerso H et al. Subcutaneous absorption of semaglutide: impact of administration site. European Journal of Pharmaceutical Sciences. 2021;159:105722.
14. Singh R et al. Peptide aggregation in GLP-1 receptor agonists: mechanisms and mitigation strategies. BioDrugs. 2023;37(2):147-162.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.